Synthetic tetrapeptide
Also called Epithalon, AEDG peptide
Epitalon is a peptide — a short chain of amino acids. It is not an approved medicine. Products sold online labelled “for research use only” are not checked by FDA for what they contain.
Every claim about Epitalon will sit in exactly one of these boxes, so you can see how strong it is:
The sorted list of claims hasn't passed scientific review yet, so we don't show it. Why?
A simple explanation of how it works hasn't passed scientific review yet, so we don't show it. Why?
Each study will show its type, size, who was studied, what was found, its limits, its date and a link to the original.
The study list hasn't passed scientific review yet, so we don't show it. Why?
For unapproved compounds, the honest answer is usually that long-term safety in people is unknown.
A sourced safety summary hasn't passed scientific review yet, so we don't show it. Why?
Not approved. FDA reviews and advisory votes are steps in a process — only an FDA approval means a product is approved.
Compounding list
FDA published a notice scheduling a Pharmacy Compounding Advisory Committee meeting and said it would remove twelve peptides from Category 2 of its interim 503A bulks list after nominators withdrew their nominations.
What this doesn't mean: Removal from Category 2 does not make a substance eligible for compounding, and it is not FDA approval.
Advisory vote
Epitalon was recommended 7–4 (1 abstention) and Semax 8–5 (1 abstention). Emideltide (DSIP) was not recommended, 6–7 (1 abstention).
What this doesn't mean: A 'yes' vote is not approval and does not yet permit compounding; a 'no' vote is not a safety finding against a substance.
Publications from PubMed and registered trials from ClinicalTrials.gov, each linked so you can check it yourself.
The reference list hasn't passed scientific review yet, so we don't show it. Why?